We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 37 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Dec 31, 2025～Jan 27, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Dec 31, 2025～Jan 27, 2026
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. KANTO CHEMICAL CO., INC. Biochemical Dept Tokyo//Chemical
  3. null/null
  4. 4 大塚化学 Tokyo//Chemical
  5. 4 Tohoku Techno Arch Co., Ltd. Miyagi//Educational and Research Institutions
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Dec 31, 2025～Jan 27, 2026
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. KANTO CHEMICAL CO., INC. Biochemical Dept
  2. Pharmaceutical CDMO services 大塚化学
  3. Natural Proteoglycan, the Herbal Medicine of the Sea バイオマテックジャパン
  4. 4 Ouchi Shinko Chemical Industry Co., Ltd. 須賀川市 経済環境部商工課
  5. 5 Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.

medicine Product List

316～330 item / All 589 items

Displayed results
[Market Report] Global Nucleic Acid Medicine Market

[Market Report] Global Nucleic Acid Medicine Market

Global Nucleic Acid Drug Market: Expected to Reach 12 Billion USD by 2031 Due to Advances in Precision Medicine and Targeted Therapies.

The global nucleic acid therapeutics market is at the forefront of the pharmaceutical industry's push towards precision medicine and targeted therapies. According to recent market reports, the global nucleic acid therapeutics market is estimated to achieve approximately $4.5 billion in revenue by 2022 and surge to $12 billion by 2031. This remarkable growth trajectory is driven by powerful compounds. The compound annual growth rate (CAGR) is projected to be 11.6% from 2023 to 2031. Nucleic acid therapeutics encompass a wide range of innovative treatments, including ribonucleic acid (RNA) therapeutics and deoxyribonucleic acid (DNA) therapeutics. These therapies further include enzymes, antisense oligonucleotides, DNA aptamers, ribozymes, micro RNA, RNA decoys, and short interfering RNA, all designed to target disease-causing genes while preserving healthy cells and tissues. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Lyme Disease Treatment Market

[Market Report] Global Lyme Disease Treatment Market

The global Lyme disease treatment market is expected to achieve steady growth, reaching 1.652 billion USD by 2031.

The global Lyme disease treatment market is aiming for significant expansion, with revenues reaching approximately $799.4 million in 2022. Recent market analysis indicates that this sector is expected to experience a robust compound annual growth rate (CAGR) of 8.4% in 2022. The forecast period is from 2023 to 2031, with an estimated value of $1.652 billion by 2031. This increase is attributed to the rising global prevalence of Lyme disease and the development of innovative treatments. As the prevalence of Lyme disease continues to rise and research efforts focus on developing more effective treatment options, the global Lyme disease treatment market is poised for continuous growth. Increased investment in research and development, expanded access to healthcare, and heightened awareness of Lyme disease among healthcare professionals and the general public are expected to lead to significant advancements in the diagnosis and treatment of this debilitating disease. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Current Status of Pain Treatment: Medical Needs, Basic Research, and Exploration of New Therapeutics

Current Status of Pain Treatment: Medical Needs, Basic Research, and Exploration of New Therapeutics

★What are the actual drug selection and treatment processes for chronic pain management? ★Profile of the desired medication, expected cascade, and promising future analgesic cascades.

【Lecturers】 Professor Shinsuke Hamaguchi, Department of Anesthesiology, Dokkyo Medical University Dr. Kenji Miki, Deputy Chief of Orthopedics, Amagasaki Central Hospital, Specialist in Pain Management, Osaka University Medical Hospital 【Venue】Industrial Promotion Hall, Conference Room 1【Kanagawa, Kawasaki Station】 【Date and Time】December 13, 2010 (Monday) 11:00-15:00 【Capacity】30 people *Registration will close once full. Please apply early. 【Participation Fee】45,150 yen per person (including tax, textbook fee, and tea cost) New members applying for the first time by December 3 will receive an early bird discount price of 39,900 yen. ◆For two applicants from the same organization, the fee is 69,300 yen. For more details or to consider applying, please use the URL below ▼ http://ec.techzone.jp/products/detail.php?product_id=1270

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Key Points of Global Quality Assurance System and Safety Assurance in GMP for Investigational Drugs

Key Points of Global Quality Assurance System and Safety Assurance in GMP for Investigational Drugs

★A thorough explanation from the basics to global compliance measures for clinical trial drug GMP, taking into account audit experience! ★Introducing many actual concrete examples, including responses to QP!

【Instructor】QA Advisor, Doctor of Medicine, Akira Nomura 【Venue】Kawasaki City Educational and Cultural Center, Room 1 　【Kanagawa, Kawasaki】10 minutes on foot from JR and Keikyu "Kawasaki Station," 12 minutes from JR Shinagawa Station to Kawasaki Station 【Date and Time】January 26, 2011 (Wednesday) 13:00-16:30 【Capacity】30 people 【Attendance Fee】45,150 yen per person (including tax and text costs)

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tateyama Chemical Co., Ltd. Quality Assurance System

Tateyama Chemical Co., Ltd. Quality Assurance System

With "creative practice" as a keyword, we are constantly reevaluating our quality assurance system.

Our company started with the production of methyl ephedrine, an active pharmaceutical ingredient (API) for expectorants. The manufacturing of APIs and their quality control are the very roots of Tateyama Chemical. Aiming for world-class quality assurance, we achieve global-level quality assurance that complies not only with Japan's GMP, which is the standard for pharmaceutical manufacturing and quality control, but also with PIC/S GMP, to supply safe, effective, and high-quality pharmaceuticals to countries around the world. To respond to the trust of various customers and ultimately the end users, we will continuously update our quality control system. 【Management Policy】 ■ Development of new products ■ Refinement of technology ■ Thorough implementation of 5S and quality control ■ Raising awareness of environmental conservation and health and safety *For more details, please refer to the PDF materials or feel free to contact us.

  • Contract manufacturing
  • Chemicals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Aptamer drug discovery technology

Aptamer drug discovery technology

Created using the SELEX method (in vitro artificial evolution method)! It is possible to develop various new drugs.

We would like to introduce our "Aptamer Drug Discovery Technology." Our core drug discovery technology, the "RiboART System," is built on comprehensive technologies, knowledge, and experience related to aptamer drug discovery, creating a platform (drug discovery foundation) that can be widely applied to the generation of new drug candidates. By using this system, it is possible to create various new drugs that are not limited to specific diseases or target proteins. 【Flow】 ■ SELEX method ■ Binding property measurement ■ Shortening, re-SELEX, chemical modification ■ Cell testing ■ Animal testing ■ Toxicity testing *For more details, please refer to the PDF document or feel free to contact us.

  • Other Protein Research

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[CPhI Seminar Report] Mutagenic Impurities in Pharmaceuticals (Active Pharmaceutical Ingredients)

[CPhI Seminar Report] Mutagenic Impurities in Pharmaceuticals (Active Pharmaceutical Ingredients)

Development of testing methods and analysis examples! Established over 300 analytical methods that can guarantee PMI residues below 10 ppm!

At "CPhI Japan 2022," we held a presentation in our booth regarding ICH M7 compliance from the Development and Analytical Research Headquarters. We introduced the day's content, including "About ICH M7," "For the Development of Trace Analysis Methods," and "Examples of Method Validation." Please take a moment to read it. [Contents] ■ About ICH M7 ■ For the Development of Trace Analysis Methods ■ Examples of Method Validation ■ Conclusion *For more details, please refer to the related links page or feel free to contact us.

  • Other Testing Contract

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Scleroderma Treatment Solutions

[Research Material] Global Market for Scleroderma Treatment Solutions

Global Market for Scleroderma Treatment Solutions: Immunotherapy, Antifibrotic Drugs, Others, Hospitals, Clinics, Others

This research report (Global Scleroderma Therapy Solutions Market) investigates and analyzes the current status and outlook for the global market for scleroderma treatment solutions over the next five years. It includes information on the overview of the global scleroderma treatment solutions market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include immunotherapy, anti-fibrotic drugs, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for scleroderma treatment solutions. It also includes the market share of major companies in the scleroderma treatment solutions sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Acute Heart Failure (AHF) Treatment Drugs

[Research Material] Global Market for Acute Heart Failure (AHF) Treatment Drugs

World Market for Acute Heart Failure (AHF) Treatment Drugs: Beta-blockers, Calcium Channel Blockers, Cardiac Glycosides, Diuretics, Morphine, Vasodilators/Nitrates ...

This research report (Global Acute Heart Failure (AHF) Therapeutics Market) investigates and analyzes the current status and outlook for the global market of acute heart failure (AHF) therapeutics over the next five years. It includes information on the overview of the global acute heart failure (AHF) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include beta-blockers, calcium channel blockers, cardiac glycosides, diuretics, morphine, vasodilators/nitrates, and others, while the segments by application focus on hospitals, clinics, and home care. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for acute heart failure (AHF) therapeutics. It also includes the market share of major companies in the acute heart failure (AHF) therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Psoriatic Arthritis Treatments

[Research Material] Global Market for Psoriatic Arthritis Treatments

World Market for Psoriatic Arthritis Treatments: Non-Steroidal Anti-Inflammatory Drugs, Disease-Modifying Anti-Rheumatic Drugs, Biological Agents, Enzyme Inhibitors, Hospitals, Clinics, Laboratories

This research report (Global Psoriatic Arthritis Therapeutics Market) investigates and analyzes the current state and outlook for the global market for psoriatic arthritis therapeutics over the next five years. It includes information on the overview of the global psoriatic arthritis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include non-steroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, biological agents, and enzyme inhibitors, while the segments by application focus on hospitals, clinics, and laboratories. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for psoriatic arthritis therapeutics. It also includes the market share of major companies in the psoriatic arthritis therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Sodium Lauryl Sulfate

[Research Material] The Global Market for Sodium Lauryl Sulfate

World Market for Sodium Lauryl Sulfate: Gastrointestinal and Metabolic Sodium Lauryl Sulfate, Constipation Treatment Sodium Lauryl Sulfate ...

This research report (Global Sodium Lauryl Sulfoacetate Market) investigates and analyzes the current status and outlook for the global sodium lauryl sulfoacetate market over the next five years. It includes information on the overview of the global sodium lauryl sulfoacetate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include gastrointestinal and metabolic sodium lauryl sulfoacetate, constipation treatment sodium lauryl sulfoacetate, and enema sodium lauryl sulfoacetate. The segments by application focus on human health, emergency medical services, laboratories, animal toxicity, and metabolism/pharmacokinetics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of sodium lauryl sulfoacetate. It also includes the market share of major companies in sodium lauryl sulfoacetate, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Systemic Psoriasis Treatments

[Research Material] Global Market for Systemic Psoriasis Treatments

Global Market for Systemic Psoriasis Treatments: Biologics, Small Molecules, Mild Psoriasis, Moderate Psoriasis, Severe Psoriasis

This research report (Global Systemic Psoriasis Therapeutics Market) investigates and analyzes the current status and outlook for the global market of systemic psoriasis therapeutics over the next five years. It includes information on the overview of the global systemic psoriasis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on biologics and small molecules, while the segments by application target mild psoriasis, moderate psoriasis, and severe psoriasis. The regional segments calculate the market size of systemic psoriasis therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in systemic psoriasis therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Anti-Obesity Therapies

[Research Material] Global Market for Anti-Obesity Therapies

Global Market for Anti-Obesity Therapies: Centrally Acting Anti-Obesity Drugs, Peripherally Acting Anti-Obesity Drugs, Hospital Use, Clinic Use, Home Use, Others

This research report (Global Anti-Obesity Therapeutics Market) investigates and analyzes the current state and outlook for the global anti-obesity therapeutics market over the next five years. It includes information on the overview of the global anti-obesity therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anti-obesity therapeutics market focus on centrally acting anti-obesity drugs and peripherally acting anti-obesity drugs, while the segments by application target hospitals, clinics, home use, and others. The regional segments calculate the market size for anti-obesity therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in anti-obesity therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Chlorhexidine Gluconate Solution

[Research Material] Global Market for Chlorhexidine Gluconate Solution

Global Market for Chlorhexidine Gluconate Solutions: 2% CHG, 4% CHG, 20% CHG, Others, Skin Preparations, Surgical, Pharmaceuticals, Others

This research report (Global Chlorhexidine Gluconate Solution Market) investigates and analyzes the current status and outlook for the global market of chlorhexidine gluconate solution over the next five years. It includes information on the overview of the global chlorhexidine gluconate solution market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include 2% CHG, 4% CHG, 20% CHG, and others, while the segments by application cover skin preparations, surgical use, pharmaceuticals, and others. The regional segments calculate the market size of chlorhexidine gluconate solution by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the chlorhexidine gluconate solution market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.